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Integrin-Linked Kinase, a Hypoxia-Responsive Molecule,
Controls Postnatal Vasculogenesis by Recruitment of
Endothelial Progenitor Cells to Ischemic Tissue
Seung-Pyo Lee, MD*; Seock-Won Youn, MS*; Hyun-Jai Cho, MD; Lian Li, BA; Tae-Youn Kim, BA;
Hyung-Seon Yook, BA; Jae-Woong Chung, MS; Jin Hur, MS; Chang-Hwan Yoon, MD;
Kyung-Woo Park, MD; Byung-Hee Oh, MD; Young-Bae Park, MD; Hyo-Soo Kim, MD
Background—Recruitment and adhesion of endothelial progenitor cells (EPCs) to hypoxic endothelial cells (ECs) is
essential for vasculogenesis in ischemic tissue; little is known, however, about the key signals or intracellular signaling
pathways involved in orchestrating the expression of adhesion molecules by ECs in response to hypoxia and how this
is related to the recruitment of EPCs to the ischemic tissue. Here, we report that endogenous integrin-linked kinase (ILK)
is a novel molecule that responds to hypoxia in ECs that regulates the expression of stromal cell–derived factor-1
(SDF-1) and intercellular adhesion molecule-1 (ICAM-1) through nuclear factor-B and hypoxia-inducible factor-1
and induces recruitment of EPCs to ischemic areas.
Methods and Results—Under hypoxia, both the endogenous amount and kinase activity of ILK were time-dependently
upregulated in ECs, which was associated with increased ICAM-1 and SDF-1. This upregulation of ILK was mediated
by stabilization of ILK by heat shock protein 90. ILK overexpression in normoxic ECs resulted in ICAM-1 and SDF-1
upregulation through dual control by nuclear factor-B and hypoxia-inducible factor-1. Blockade of ILK in hypoxic
ECs significantly abrogated the expression of both molecules, which led to decreased EPC incorporation into ECs. A
hindlimb ischemia model showed that ILK blockade significantly reduced EPC homing to ischemic limb and
consequently led to poor neovascularization. Overexpression of ILK in the Matrigel plug significantly improved
neovascularization in vivo, whereas the blockade of ILK resulted in the opposite effect.
Conclusions—Endogenous ILK is a novel and physiological upstream responder of numerous intracellular molecules
involved in hypoxic stress in ECs and may control the recruitment of EPCs to ischemic tissue. (Circulation. 2006;114:
150-159.)
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Vasculogenesis, a process of new vessel formation byangiogenic progenitor cells, has been a “hot” issue since
the discovery of endothelial progenitor cells (EPCs) in human
peripheral blood.1 For selective recruitment of EPCs to ischemic
tissue after mobilization, “activation” of quiescent endothelial
cells (ECs) and “adhesion” of EPCs to “activated” hypoxic ECs
in the tissue is essential. The family of integrins is deeply
involved in these processes of activation and adhesion.
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CXC chemokine receptor 4 (CXCR4) and 2-integrin,
expressed on EPCs, play crucial roles in the homing of these
cells to the ischemic tissue,2,3 whose counterpart molecules,
stromal cell–derived factor-1 (SDF-1) and intercellular adhe-
sion molecule-1 (ICAM-1), respectively, are expressed by
ECs.3 However, little is known about the intracellular signal-
ing pathways involved in orchestrating the expression of
these molecules by ECs in response to hypoxia and how this
is related to the recruitment of EPCs to the ischemic tissue.
Integrin-linked kinase (ILK) is a 59-kDa Ser/Thr kinase
that binds to the cytoplasmic domain of -integrin4 and lies
upstream of Akt/PKB,5,6 mitogen-activated protein (MAP)
kinase,7 and nuclear factor (NF)-B,8,9 important molecules
in inflammation and neovascularization. Recently, ILK was
found to be involved in vessel formation during embryonic10
or tumor11 development. In addition, we recently showed that
the level of endogenous ILK changes in EPCs and ECs after
anchorage and nutrient deprivation.6
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Therefore, we postulated that endogenous ILK in ECs
would be important in regulating pathways responsible for
the expression of key molecules during vasculogenesis in
response to hypoxia. We show here for the first time that ILK
is a novel regulator of EC response to hypoxia and controls
the homing of EPCs to ischemic tissue.
Methods
All materials and methods used for experimental procedures can be
found in the online-only Data Supplement.
The authors had full access to the data and take full responsibility
for its integrity. All authors have read and agreed to the manuscript
as written.
Results
Hypoxia Upregulates ILK and Its Downstream
Molecules in ECs In Vitro and In Vivo
For analysis of the changes in ILK and the proposed down-
stream molecules in response to hypoxia, human umbilical
vein endothelial cells (HUVECs) were exposed to 1% O2
hypoxic stress in a time-sequential manner. ILK was upregu-
lated after 30 minutes of hypoxic stress and up to 24 hours in
a time-dependent manner (Figure 1A). Phospho-Akt (p-Akt)
and phospho-Erk (p-Erk) were also upregulated in 30 minutes
and showed a biphasic increase at 6 and 24 hours of hypoxia,
whereas the total amount of Akt and Erk remained unchanged
(online Data Supplement Figure I). Because activation of the
IB kinase (IKK) and degradation of the inhibitor of NF-B
(IB) would lead to the nuclear translocation of NF-B,8 the
level of intracellular IB was measured to detect the degree
of nuclear translocation of NF-B. IB was downregulated,
in contrast to hypoxia-inducible factor-1 (HIF-1) and
ICAM-1, which were upregulated after 1 and 3 hours of
hypoxia, respectively (Figure 1A; online Data Supplement
Figure I). SDF-1, which is known to be secreted and
expressed on the surface of hypoxic ECs,3 was upregulated in
response to the hypoxic stress as measured by ELISA (Figure
1B). In addition to assessing the total amount of ILK in
hypoxia, the kinase activity of ILK was also measured with
an in vitro kinase assay. With the same amount of ILK
immunoprecipitated, the degree of phosphorylation of a given
substrate, glycogen synthase kinase–3, was greater in im-
munoprecipitated ILK from hypoxic HUVECs than in nor-
moxic HUVECs (Figure 1C). Thus, ILK was increased not
only in its amount but also in its kinase activity under
hypoxia.
To confirm that the upregulation of ILK, ICAM-1, and
SDF-1 also takes place in vivo, we used an established model
Figure 1. Changes in ILK, ICAM-1, and SDF-1 in response to hypoxia. A, Serial immunoblot analysis of the expression of ILK and
ICAM-1 (n4). B, SDF-1 excretion from hypoxic ECs measured by ELISA (*P0.05 vs baseline SDF-1; n3, meanSEM). C, In vitro
kinase assay of ILK from hypoxic or normoxic HUVECs. D, Ischemic hindlimb made by excision of unilateral femoral vessel. Laser
Doppler perfusion imaging was taken just after the operation to confirm the induction of significant ischemic hindlimb (a); b denotes
nonischemic control hindlimb. E–G, Costaining of both limbs with BS1-lectin and ILK (E), BS1-lectin and SDF-1 (F), and BS1-lectin and
ICAM-1 (G).
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of ischemic hindlimb in mouse.12 Laser Doppler imaging just
after the operation confirmed the significant hypoxia induced
by the procedure (Figure 1D), and the tissue specimens were
harvested 6 hours after surgery. ECs in the ischemic limb
showed significantly higher expression of intracellular ILK
levels than nonischemic limb by immunofluorescence stain-
ing (Figure 1E). The hypoxia-induced increase in ILK was
associated with increased SDF-1 (Figure 1F) and ICAM-1
(Figure 1G).
ILK Is Stabilized in Hypoxia by Heat Shock
Protein 90
Given the previous finding that the amount of ILK was
upregulated in hypoxic ECs, the mechanism underlying this
finding was further elucidated. First, ECs were exposed to
hypoxia and harvested for reverse transcription–polymerase
chain reaction at certain time points to look for the possibility
of transcriptional activation of ILK. The mRNA level of ILK
did not change in response to hypoxia (Figure 2A), which led
us to hypothesize that stabilization, rather than increased
transcription of ILK, would be the cause of increased ILK. To
verify this hypothesis, ECs were exposed to hypoxia for 24
hours, and puromycin, a synthetic inhibitor of protein syn-
thesis, was added for the indicated time to block new
synthesis of ILK and to examine the pure effect of intrinsic
stabilization, as shown in previous reports.13 The level of
ILK, shown by Western blot, significantly increased in
hypoxic HUVECs compared with normoxic HUVECs despite
puromycin treatment (Figure 2B), which suggests that ILK
was stabilized under hypoxic conditions.
Heat shock protein 90 (Hsp90), a well-known heat shock
protein, is known to be a chaperone of various unstable
intracellular proteins, such as endothelial NO synthase.14
Therefore, we postulated that Hsp90 could prevent the natural
degradation of ILK. Treatment of hypoxic HUVECs with a
synthetic Hsp90 inhibitor, 17-allylamino-17-demethoxygeld-
anamycin, abrogated the stabilization of ILK, resulting in
decreased ILK despite hypoxia (Figure 2C), which suggests
that Hsp90 is essential for stabilization of ILK in hypoxic
ECs.
ILK Is an Important Upstream Regulator of
ICAM-1 and SDF-1 Expression in ECs
On the basis of these results, we postulated that ILK could be
an important upstream regulator of ICAM-1 and SDF-1. For
overexpression and blockade of the kinase activity of ILK,
adenovirus encoding ILK (adv-ILK) or a kinase-deficient,
dominant-negative form of ILK (adv-dead ILK) was con-
structed with the appropriate plasmid. The kinase activity of
both adenoviruses was confirmed in an in vitro kinase assay
with glycogen synthase kinase–3 as described15 previously
(online Data Supplement Figures IIA and IIB).
To verify the effect of overexpressing ILK in normoxic
ECs, adv-ILK–transfected HUVECs were analyzed with
Figure 2. Mechanism of upregulation of endogenous ILK in hypoxic ECs. A, mRNA level of ILK at certain time points after hypoxia
(n3). B, Level of ILK in puromycin-treated normoxic and hypoxic HUVECs. Before puromycin treatment, HUVECs were exposed to
normoxia or hypoxia for 24 hours. Data points in the plot indicate the percentage of ILK protein remaining compared with -tubulin
after puromycin treatment. *P0.05 vs the same time point of normoxic ECs (n3). C, Attenuation of the hypoxia-induced ILK increase
by inhibition of Hsp90 in hypoxic HUVECs. HUVECs were treated with an Hsp90 inhibitor, 17-allylamino-17-demethoxygeldanamycin,
on initiation of hypoxia for 24 hours. Tx indicates treatment.
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Western blot, immunofluorescence staining, and ELISA.
Transfection of adv-ILK into normoxic ECs resulted in
upregulation of p-Akt, p-Erk, HIF-1, ICAM-1, and SDF-1
while downregulating IB (Figures 3A and 3B). Upregula-
tion of the final effector molecules, ICAM-1 and SDF-1, was
also confirmed by immunofluorescence staining (online Data
Supplement Figures IIC and IID).
Next, we tested whether the hypoxia-induced increase in
SDF-1 and ICAM-1 was mediated via ILK by analyzing the
effects of adv-dead ILK transfection in hypoxic ECs. Indeed,
reversal of ILK activation by adv-dead ILK transfection
resulted in a significant attenuation of downstream molecules
in response to hypoxia. Hypoxia failed to upregulate p-Akt,
p-Erk, HIF-1, ICAM-1, and SDF-1 and failed to downregu-
late IB in ECs transfected with adv-dead ILK (Figures 3C
and 3D), which was also confirmed with immunofluores-
cence staining (online Data Supplement Figures IIE and IIF),
which suggests that ILK is an important upstream regulator of
ICAM-1 and SDF-1 in hypoxic ECs.
Upregulation of ICAM-1 and SDF-1 by ILK Is
Dual-Regulated by HIF-1 and NF-B
Given the previous findings that ILK is upregulated at an
early time point of ischemia in ECs and that overexpression
of ILK leads to upregulation of ICAM-1 and SDF-1, the
downstream pathways regulating the expression of ICAM-1
and SDF-1 by ILK were studied. We overexpressed ILK in
HUVECs using adv-ILK and applied chemical blockers to
each downstream molecule. The expression of each down-
stream molecule was assessed with Western blot and ELISA.
Despite overexpression of ILK by adenoviral transfection,
which leads to the overexpression of ICAM-1 and SDF-1, the
addition of LY294002, PD98059, 3-(5-hydroxymethyl-2-
furyl)-1-benzyl indazole, or sulfasalazine, chemical inhibitors
of p-Akt, p-Erk, HIF-1, and NF-B, respectively, all
blocked the ILK-induced expression and production of
ICAM-1 (Figure 4A) and SDF-1 (Figure 4B). Interestingly,
although expression of the downstream molecule ICAM-1
was decreased, HIF-1 expression was only decreased by
inhibition of p-Akt and not by inhibition of p-Erk, which
suggests that p-Akt can regulate HIF-1 by controlling its
translation, whereas p-Erk can only regulate the activity and
not the amount of HIF-1, which is concordant with a
previous report.16
These results, along with previous reports that SDF-1 is
regulated by the transcription factor HIF-13 and ICAM-1 by
NF-B,17 suggested to us that SDF-1 and ICAM-1 expression
is under dual regulation by both HIF-1 and NF-B. To
prove this hypothesis and to find out which transcription
factor has the dominant effects, we performed a chromatin
immunoprecipitation (ChIP) assay as described previously.3
As expected, SDF-1 and ICAM-1 were under direct regula-
tion of both HIF-1 and NF-B (Figure 4C), but SDF-1 was
more dominantly regulated by HIF-1, whereas ICAM-1 was
more dominantly regulated by NF-B. In addition to the ChIP
assay, the mechanism of SDF-1 and ICAM-1 upregulation by
Figure 3. Effect of ILK signaling on SDF-1 and ICAM-1 expression in normoxic and hypoxic ECs. A, Change in downstream molecules
after transfection of adv-ILK in normoxic HUVECs (n3). B, Upregulation of SDF-1 in normoxic HUVECs after adv-ILK transfection.
*P0.05 vs mock and GFP (n3). C, Effect of blocking ILK on each downstream molecule in hypoxic HUVECs (n3). D, Downregula-
tion of SDF-1 in hypoxic HUVECs after blocking ILK with adv-dead ILK transfection. *P0.05 vs adv-GFP transfected normoxic ECs,
**P0.05 vs adv-GFP transfected hypoxic ECs (n3).
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adv-ILK transfection was investigated at the transcriptional
level with reverse transcription–polymerase chain reaction.
Transfection of adv-ILK resulted in increased mRNA level of
both ICAM-1 and SDF-1. Inhibition of NF-B by sulfasala-
zine and HIF-1 by YC-1 resulted in decreased mRNA levels
of SDF-1 and ICAM-1 (Figure 4D), which suggests that the
upregulation of ICAM-1 and SDF-1 was controlled at the
transcriptional level, under the control of HIF-1 and NF-B.
ILK Activity Controls EPC Recruitment In Vitro
and In Vivo
Because SDF-1 and ICAM-1 are counterparts of CXCR4 and
2-integrin on EPCs, respectively, and are important in EPC
recruitment to ischemic tissue,2,3 we investigated the effect of
ILK modulation on the incorporation of EPCs into the
normoxic EC layer in vitro. Either adv–green fluorescent
protein (GFP) or adv-ILK was transfected into normoxic
HUVECs, and an incorporation assay was performed as
described previously.18 Overexpression of ILK in normoxic
HUVECs resulted in significantly improved EPC incorpora-
tion into ECs. Coincubation with either anti–ICAM-1 or
SDF-1 neutralizing antibody resulted in significantly de-
creased EPC incorporation, whereas coincubation with both
neutralizing antibodies had greater effects on attenuating EPC
incorporation than any single antibody (Figure 5A; online
Data Supplement Figure IIIA), which confirms the significant
role that both SDF-1 and ICAM-1 play in EPC incorporation.
To identify the role of ILK in the incorporation of EPCs
into hypoxic ECs, incorporation assay was done under
hypoxia with either adv-GFP– or adv-dead ILK–transfected
HUVECs. HUVECs under hypoxia incorporated more EPCs
than normoxic HUVECs, but this finding was significantly
attenuated when hypoxic HUVECs were transfected with
adv-dead ILK (Figure 5B; online Data Supplement Figure
IIIB).
To confirm the above in vitro findings in vivo, both
femoral vessels of athymic nude mice were ligated, and EPCs
were injected systemically by intracardiac puncture. One
ischemic hindlimb was injected intramuscularly with adv-
GFP while the other was injected with adv-dead ILK to make
both hindlimbs compete with each other for EPC recruitment.
Immunofluorescence staining with anti-SDF-1 and anti–
ICAM-1 in both limbs showed decreased expression of both
molecules in the adv-dead ILK–injected limb. These 2
molecules were localized in the interstitial space, mainly
around preexisting vessels, whereas there was no staining of
SDF-1 and ICAM-1 in the muscle area (Figure 5C). This was
associated with decreased EPC recruitment to ischemic tis-
Figure 4. Mechanistic analysis of SDF-1 and ICAM-1 production by 2 transcription factors, HIF-1 and NF-B. A, Expression of each
downstream molecule after treatment of adv-ILK–transfected HUVECs with each specific chemical blocker for p-Akt, p-Erk, HIF-1,
and NF-B. V indicates vehicle (DMSO); L, LY294002; P, PD98059; S, sulfasalazine; and Y, 3-(5-hydroxymethyl-2-furyl)-1-benzyl inda-
zole (n3). B, SDF-1 secretion from HUVECs cultured in the same conditions as Figure 4A. *P0.05 vs adv-GFP transfected ECs,
**P0.05 vs adv-ILK–transfected ECs, P0.05 vs adv-ILK–transfected ECs treated with either LY294002, PD98059, or sulfasalazine
only (n4). C, ChIP analysis of SDF-1 and ICAM-1 specific genomic sequences from adv-ILK– or adv-GFP–transfected HUVECs with
anti-HIF-1 and NF-B (p65) monoclonal antibodies. D, Reverse transcription–polymerase chain reaction of ICAM-1 and SDF-1 in adv-
ILK–transfected HUVECs after treatment of specific chemical inhibitors of HIF-1 and NF-B.
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sue, as measured by manual cell counting of the number of
DiI-tagged EPCs in the tissue (Figure 5C; online Data
Supplement Figure IIIC). DiI-tagged EPCs were colocalized
to areas where SDF-1 and ICAM-1 was strongly expressed,
mainly in the interstitial space of ischemic tissue (Figure 5D),
when immunofluorescence stainings with anti-SDF-1 and
anti–ICAM-1 were merged with the pictures for recruited
EPCs. These findings demonstrate that ILK is a regulator of
EPC recruitment to ischemic ECs in vitro and in vivo.
ILK Activity Controls Neovascularization In Vivo
To verify the role of ILK activity in controlling new vessel
formation in hypoxic tissue, we used 2 models of ischemia,
an ischemic hindlimb model and an in vivo Matrigel model.
Because bilateral hindlimb ischemia showed an exceptionally
high mortality rate in athymic nude mouse, the unilateral
hindlimb ischemia model was used for the follow up of serial
laser Doppler perfusion imaging analyses. Blocking ILK
activity in the ischemic limb with adv-dead ILK transfection
resulted in limb amputation (autoamputation/foot necrosis/
limb salvage: 6/0/0), whereas the natural augmentation of
ILK activity in control, adv-GFP limbs resulted in a signifi-
cant increase in limb perfusion time sequentially (Figures 6A
and 6B; online Data Supplement Figure IVA) and thus less
amputation (autoamputation/foot necrosis/limb salvage:
1/4/1; online Data Supplement Figure IVB). Capillary stain-
ing of the ischemic limb with BS1-lectin showed poor
neovascularization in adv-dead ILK–transfected mice (Figure
6C) and BS1-lectin–positive cells (Figure 6D).
The in vivo Matrigel assay showed similar results. Plugs
mixed with adv-ILK were associated with significantly
higher infiltration of cells than plugs mixed with adv-GFP or
adv-dead ILK, as seen by hematoxylin-and-eosin staining
(Figure 7A). The infiltration of CD31- and alkaline phos-
phatase–positive ECs was greatest in the adv-ILK plugs and
poorest in the adv-dead ILK plugs. Moreover, there were
significantly more vascular networks that penetrated the plug
from the muscle layer and more vascular branches in the
Matrigel in the adv-ILK plugs, as seen by the BS1-lectin and
phase-contrast merged image (Figure 7A). In particular, the
adv-ILK Matrigel plugs showed morphologically mature
vessels in contrast to adv-GFP or adv-dead ILK Matrigel
plugs, which only showed dispersed ECs (Figure 7A). These
findings were confirmed by counting the CD31- and alkaline
phosphatase–positive cells (Figure 7B). Although there was
an insignificant decrease of alkaline phosphatase–positive
cells in adv-dead ILK Matrigel, there was a significant
increase and decrease in CD31-positive ECs infiltrating both
adv-ILK and adv-dead ILK Matrigel, respectively. These in
vivo findings suggest that ILK activity is important in
controlling neovascularization.
Figure 5. Effect of ILK modulation on EPC recruitment in vitro and in vivo. A, Effect of ILK overexpression on EPC incorporation in nor-
moxic HUVECs. Ten random fields were counted from each set of experiments. HPF indicates high-power field; ILKIS, adv-
ILKanti–ICAM-1anti-SDF-1; C, control antibody. *P0.05 vs adv-GFP–transfected ECs; **P0.05 vs adv-ILK–transfected ECs and
adv-ILK–transfected ECs coincubated with control antibody; P0.05 vs adv-ILK–transfected ECs coincubated with either anti–
ICAM-1 or anti-SDF-1 neutralizing antibody (n4). B, Effect of blocking ILK activation on EPC incorporation in hypoxic HUVECs.
GFPH indicates adv-GFP–transfected hypoxic ECs; Dead-ILKH, adv-dead ILK–transfected hypoxic ECs. *P0.05 vs adv-GFP–
transfected normoxic ECs; **P0.05 vs adv-GFP–transfected hypoxic ECs (n3). C, Changes in SDF-1 and ICAM-1 expression and
DiI-EPC homing in hypoxic hindlimb after blocking of ILK. Bilateral hindlimb ischemia was induced with 1 limb injected with adv-GFP
and the other with adv-dead ILK, and a total of 1106 DiI-labeled EPCs were injected systemically via intracardiac puncture. D, Repre-
sentative figure showing EPC homing to ischemic vessels coexpressing SDF-1 and ICAM-1. All scale bars are 100 m.
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Discussion
The most important findings of the present study are that in
ECs, endogenous ILK is a novel intracellular responder to
hypoxic stress and that it lies upstream of important regula-
tors of hypoxia, HIF-1 and NF-B, controlling the expression
of SDF-1 and ICAM-1, key molecules previously shown to
be involved in selective recruitment of EPCs during vascu-
logenesis. The present study has several novel findings. First,
we found that ILK is an endogenous, intracellular responder
to hypoxia in ECs. Second, we showed that ILK could be
stabilized by Hsp90 under hypoxic conditions in ECs. Third,
we showed that HIF-1 is regulated by ILK via Akt/PKB and
MAP kinase in an O2-dependent manner. Fourth, not only
were SDF-1 and ICAM-1 regulated by HIF-13 and NF-B,17
respectively, but there was also cross regulation of SDF-1 by
NF-B and of ICAM-1 by HIF-1. Finally, genetic modulation
of ILK in ECs was shown to regulate postnatal neovascular-
ization in vivo. This study not only shows that ILK is a key
signaling molecule in hypoxic ECs but also extends our
knowledge on the role of ILK in neovascularization.
ILK was reported to be an important regulator of angio-
genesis.10,11 There have not been any reports, however, about
the intracellular signals involved in this pathway, nor has the
role of ILK been investigated in the response of ECs to
hypoxia. Previously, it was shown that the Akt/PKB,19
Erk/MAP kinase,20 and NF-B21 pathways are involved in
hypoxic cell signaling in ECs, which in turn have all been
proved to be downstream molecules of ILK in various
epithelial cells.6,7,9 Thus, we hypothesized that ILK may
function as a regulator of the intracellular signaling in
hypoxic ECs and, ultimately, a regulator of ICAM-1 and
SDF-1. From our results, we propose a scheme for the
intracellular signaling pathways involved in EPC recruitment
in Figure 8. Although this scheme is shown as a 1-way
pathway, the possibility of an autocrine circuit that involves
SDF-13p-Akt3CXCR43SDF-1,22 shown as a dotted ar-
row in Figure 8, cannot be ignored. In fact, ILK has been
shown to be involved in this autocrine circuit, and inhibition
of ILK in hypoxic ECs leads not only to decreased SDF-1
expression but also to CXCR4 expression (data not shown).
The present results also suggest that upregulation of ILK in
hypoxia is due to increased protein stabilization rather than
transcription, because ILK mRNA was not changed after
hypoxia, and ILK decreased after the addition of an Hsp90
inhibitor. Hsp90 was previously reported to be a stabilizer of
ILK in 293T cell lines, and enhanced expression of Hsp90
resulted in increased intracellular levels of ILK,23 but the
present finding of ILK and Hsp90 interaction in ECs is novel.
Although protein stabilization of ILK accounted for the
upregulation of ILK in hypoxic ECs, the mechanism of
persistent ILK production was not elucidated in this work.
There are few previous works on this subject, and ILK has
Figure 6. Effect of blocking of ILK on neovascularization in hindlimb ischemia model. A and B, Improvement of ischemic hindlimb per-
fusion in adv-GFP–injected groups compared with adv-dead ILK–injected groups after induction of hindlimb ischemia and EPC injec-
tion. Laser Doppler perfusion imaging was checked at day 3, 7, 14, and 21 after operation, and recovery of perfusion was assessed.
*P0.05 vs adv-GFP–transfected limb (n5 or 6 for each group). C, Capillary density of adv-GFP–injected control ischemic limb vs
adv-dead ILK–injected ischemic limb 21 days after operation. All scale bars are 100 m. D, Degree of neovascularization in each ische-
mic hindlimb was corroborated with cell counting of BS1-lectin–positive ECs (*P0.05 vs adv-GFP–transfected limb).
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previously been described to be upregulated by transforming
growth factor (TGF)- in renal tubular epithelial cells.24
However, neither blockade of TGF- with neutralizing anti-
body nor blockade of intracellular TGF- signaling with
Smad7 transfection could block the upregulation of ILK in
hypoxic ECs (data not shown). In a previous report by
Melchior et al,25,26 there were 2 isoforms of ILK, namely,
ILK1 and ILK2, that could only be discriminated by BamHI
cDNA restriction. ILK1, which has no TGF- responsive
element in its promoter site and is not restricted by BamHI,
was found to have typical characteristics of a housekeeping
gene. In concordance with these characteristics, the upregu-
lation of ILK in the present set of experiments was found to
have the same characteristics of ILK1, the cDNA of which
was not restricted by BamHI restriction and the production of
which was not blocked by blocking TGF- (data not shown).
This may explain in part why ILK is persistently produced in
ECs and why the ILK level decreases after puromycin
treatment.
In addition, Akt/PKB and Erk/MAP kinase activity has
been known to be upregulated at 30 minutes and downregu-
lated in 2 hours in response to hypoxia.27 In the present study,
Akt/PKB and Erk phosphorylation showed a biphasic re-
sponse, increasing up to 6 hours. The difference in the
duration of enhanced expression may be due to the type of
ECs and culture medium used for the experiment. In the
present study, the upregulation of ILK occurred at 30 minutes
of exposure to hypoxia in vitro, which suggests that ILK is a
very early, if not a primary, responder to hypoxia.
The regulation of SDF-1 and ICAM-1 by both HIF-1 and
NF-B implies that the expression or production of end
products in hypoxia is not regulated by a single pathway but
rather by a complex network of several transcription factors.
However, the binding of HIF-1 to the SDF-1 promoter site
was stronger than that to ICAM-1, and the opposite was true
for NF-B, as shown in the ChIP assay, which suggests that
Figure 7. Effect of ILK modulation on in vivo Matrigel implantation model. A, Representative figures of each Matrigel stained for specific
markers of ECs, CD31, alkaline phosphatase (ALP), and BS1-lectin. All scale bars are 100 m (n4 for each group). B, Manual count-
ing of cells positive for CD31 and alkaline phosphatase. Five random fields were chosen and counted for each section of each Matrigel
(*P0.05 vs adv-GFP Matrigel). H&E indicates hematoxylin and eosin.
Figure 8. Schematic model of SDF-1 and ICAM-1 expression
under the control of ILK in hypoxic ECs. Hypoxia increases the
amount and activity of ILK in ECs, where Hsp90 is involved in
its stabilization. ILK in turn phosphorylates and activates Akt/
PKB and MAP kinase. These are associated with stabilization of
HIF-1 and its nuclear translocation. Another downstream mole-
cule of ILK is IKK, which degrades IB, leading to NF-B
nuclear translocation. HIF-1 and NF-B work together to
express various molecules involved in EPC recruitment, such as
SDF-1 and ICAM-1, which in turn cooperate to selectively home
EPCs to ischemic tissue.
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although effector molecules are controlled by several tran-
scription factors, there may be certain signals that are more
predominant. Maintaining a complex web of signaling may
be a means of maintaining the ability to respond to various
exogenous stresses in an organism, even if a single pathway
may be blocked.
Selective recruitment and binding of leukocytes to in-
flamed endothelium is a critical step in inflammation. Like-
wise, we speculated that the same process would be important
in vasculogenesis, because EPCs share many common fea-
tures, such as surface molecules, with peripheral blood
monocytes.28 CXCR4 and 2-integrin on EPCs have been
shown to be important molecules for chemotaxis and binding
of EPCs to ischemic vessels.2,3 On the basis of these previous
results, we hypothesized and demonstrated that the presence
of SDF-1 and ICAM-1 on hypoxic ECs is important for
adhesion of EPCs to hypoxic ECs and thus for selective
recruitment of EPCs to ischemic tissue. Of course, the
possibility that EPCs may reside in the pericellular area in the
incorporation assay done in vitro and that EPCs also may be
recruited to the perivascular area and not actually incorpo-
rated into the neovessels in vivo cannot be overlooked.
Nonetheless, the main thesis of the present study was to show
the importance of ILK in recruiting these EPCs to hypoxic
ECs rather than the role of EPC itself in new vessel
formation. Although there may be several molecules respon-
sible for EPC recruitment, and EPC-associated neovascular-
ization may not be entirely responsible for ischemic tissue
salvage, homing of the EPCs by SDF-1 and ICAM-1 in
hypoxic vessels may be an important component of ischemic
tissue salvage, as shown in Figure 8.
Finding strategies to control vasculogenesis is an area of
intense interest in the field of cardiovascular research. Op-
tions to maximize the efficiency of vasculogenesis include
mobilization of EPCs, functional modification of mobilized
EPCs, and selective recruitment of EPCs to ischemic areas.
Considering the scarcity of EPCs even in mobilized periph-
eral blood, optimizing the selective recruitment of EPCs to
ischemic areas would be an efficacious method of enhancing
vasculogenesis, and it would be very helpful to find the key
molecule in this process. In association with our previous
findings,6 ILK may be a good candidate molecule, either for
enhancing the function of EPCs or for enhancing the recruit-
ment of EPCs to ischemic tissue.
In conclusion, ILK is an important intracellular molecule
that regulates the response of ECs to hypoxic stress, and
modulating the activity of ILK would be a good target to
control the process of vasculogenesis. Unraveling the natural
response of ECs to exogenous stimuli may provide good
novel targets to enhance or suppress EPC recruitment and
neovascularization.
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CLINICAL PERSPECTIVE
For clinicians facing the difficult task of saving organs or tissues at risk of ischemic death every day, enhancing the growth
of blood vessels can be an attractive method of saving these organs. Since the discovery of endothelial progenitor cells
(EPCs) in adult human peripheral blood, clinicians are now faced with the problem of augmenting the recruitment of these
cells to the most appropriate tissue. Although understanding the mechanism of this homing process can be a crucial step
in bringing this procedure into clinical practice, there have been few reports on this problem. What is the key molecule that
orchestrates the expression of adhesion molecules in hypoxic endothelium, and how does it do so? How is this related to
the recruitment of EPCs to the appropriate, ischemic tissue? Does control of this molecule ultimately lead to control of
neovascularization? These are the key questions that we tried to answer. In this work, integrin-linked kinase (ILK) has been
shown to be an important mediator of neovascularization, possibly by controlling the homing of EPCs to ischemic tissue.
Furthermore, this process was mediated by stromal cell–derived factor-1 and intercellular adhesion molecule-1, the key
molecules known to be important in EPC recruitment in ischemic tissue; ILK has also been found to be upstream of various
molecules known to be responsive to ischemia, such as hypoxia-inducible factor-1 and nuclear factor-B. In conclusion,
this work provides new insight into the mechanism of neovascularization by EPC recruitment and emphasizes the possible
importance of manipulating ILK in ischemic tissue in the future.
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